CROI 2025
Crushing/Dissolving HIV Medications Effective in Hospitals
Providing dissolved or crushed bictegravir-emtricitabine-tenofovir alafenamide through an enteral tube can achieve ...
AUGUST 18, 2025
Trial Shows Lenacapavir + bNAbs As Possible HIV Treatment
New longer-acting treatment options for HIV may be on the horizon.
JULY 31, 2025
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 9, 2025
Study Finds 1 INSTI Combo Fares Better With Weight Gain
How do you pick which drug to prescribe for your patients with HIV?
MARCH 26, 2025
Good Results With Biktarvy in HIV–HBV Coinfection
At CROI 2025, Dr. Anchalee Avihingsanon and her colleagues reported Week 48 outcomes from the open-label extension ...
MARCH 25, 2025
Real-World Data Show Continued Virologic Suppression With Cabenuva
At CROI 2025, new research has shown high rates of continued virologic suppression with cabotegravir-rilpivirine ...
MARCH 25, 2025
People With HIV Can Have Normal Lives
People with HIV can have a normal life that includes work, family and a loving relationship, said long-term HIV ...
MARCH 21, 2025
Ensitrelvir Reduced the Risk for COVID-19 by 67%
Ensitrelvir, an antiretroviral being developed to prevent COVID-19, reduced the risk of developing the infection by ...
MARCH 14, 2025
Although Safe, Tecovirimat Proves Ineffective for Treating Clade II Mpox
More data from the STOMP trial presented at CROI 2025, held in San Francisco, confirms that tecovirimat does not ...
MARCH 14, 2025
Co-Circulating Viruses Causing Concern in Mpox Outbreak
The mpox outbreak in the Democratic Republic of Congo has spilled over into Uganda, which borders the DRC, ...
MARCH 14, 2025
CROI Chair Calls Disruption of HIV Services ‘Cataclysmic and Cruel’
CROI 2025 is taking place during a tumultuous period for the scientific community here and abroad, according to ...
MARCH 12, 2025
